pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,765 catalysts · 3,382 8k filing · 2,401 grant · 2,059 approval · 1,416 device 510k · 1,000 device adverse event · 949 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 33 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: recall×type: grant×from 2025-10-30×clear all
type
  • 8k filing3,382
  • grant2,401
  • approval2,059
  • device 510k1,416
  • device adverse event1,000
  • device recall949
device pma
941
  • earnings584
  • recall364
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Oct 27, 2025

    24
    ›Nov 1, 2025grant290d agoUNIVERSITY OF COLORADO DENVER — Enhancement of Effector CD8 Cell Motility through Mitochondrial MetabolismUniversity of Colorado Denver

    AI grant. $38,093. PI: Maureen E Hoen Rauhut

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoYALE UNIVERSITY — Impact of Natural Infection on the Baseline Immune States in Humans

    AI grant. $34,558. PI: Yona Lei

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoEMORY UNIVERSITY — Capsid assembly mechanisms of Kaposi Sarcoma associated herpesvirusEmory University

    AI grant. $78,052. PI: Shea Lowery

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoPRINCETON UNIVERSITY — Molecular and Cellular Determinants of Tolerance to Second Generation Antipsy...

    MH grant. $33,538. PI: Elinor Lewis

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoBROWN UNIVERSITY — TAC1 Tango: Evolutionary rewiring of a transcriptional circuit for azole drug...

    AI grant. $75,520. PI: Nicholas Cauldron

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

    AI grant. $19,000. PI: JASON B HARRIS

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Oral Microbiome Dysregulation as a Contributor to Depressive Symptoms and Alt...University of California Los Angeles

    MH grant. $42,489. PI: Naomi Gancz

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoJOHNS HOPKINS UNIVERSITY — Microbiota mechanisms promoting Clostridioides difficile colon persistenceJohns Hopkins University

    AI grant. $49,538. PI: Hadley Beauregard

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoHARVARD MEDICAL SCHOOL — Molecular Transport of IFT Complexes in Leishmania

    AI grant. $44,020. PI: Tierra Buck

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — How does myelin plasticity influence neural circuit dynamics required for lon...University of California San Francisco

    MH grant. $75,052. PI: Manasi Iyer

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

    AI grant. $99,429. PI: JASON B HARRIS

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Longitudinal Impact of Health and Lifestyle Behaviors on Cognition in Individ...

    HD grant. $75,600. PI: Michelle H Chen

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Syphilis Immunology and Biology to Improve Clinical Management and Vaccine De...University of Southern California

    AI grant. $238,136. PI: Jeffrey David Klausner

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF TEXAS MED BR GALVESTON — Initiate Research, Opportunities, and Networks for Early Career Investigators...

    DK grant. $103,081. PI: Brittany L. Smalls

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Triggers of food allergen absorption and anaphylaxisNorthwestern University

    AI grant. $53,461. PI: Danielle Rose Jacobsen

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoEMORY UNIVERSITY — Molecular determinants of Streptococcus pyogenes adhesion to pyroptotic kerat...Emory University

    AI grant. $49,538. PI: Jacob D Sherman

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoVANDERBILT UNIVERSITY MEDICAL CENTER — All of Us Research Program Data and Research Center

    OD grant. $2,500,000. PI: Melissa Basford

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF IOWA — Developing real-time personalized TMS to target residual corticospinal connec...University of Iowa

    NS grant. $245,687. PI: Sara J Hussain

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoOHIO STATE UNIVERSITY — Epigenetic Regulation of KSHV

    AI grant. $85,360. PI: Kurtis Matthew Host

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoJOHNS HOPKINS UNIVERSITY — Chemosensory Mechanisms Driving Malaria TransmissionJohns Hopkins University

    AI grant. $103,760. PI: Conor James McMeniman

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — 2025 Rachmiel Levine-Arthur Riggs Diabetes Research SymposiumCity of Hope

    DK grant. $20,000. PI: FOUAD R KANDEEL

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF CALIFORNIA BERKELEY — Elucidating the mechanism and correlates of protection elicited by CDN adjuva...

    AI grant. $48,395. PI: Isabel Lamb-Echegaray

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Strategies and Consequences of Polymicrobial Nasal Colonization

    AI grant. $75,520. PI: Shyra Wilde

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoSTANFORD UNIVERSITY — Predicting Japanese Encephalitis Spillover Risk in the United StatesStanford University

    AI grant. $75,052. PI: Rachel Lucy Fay

    full page →nih reporter ↗

    Week of Nov 3, 2025

    26
    ›Nov 5, 2025recall286d agoProRx LLC recall (Cls II)Novo Nordisk AS

    Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-04 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall
    ← prev
    page 1 of 56
    next →
    286d ago
    ProRx LLC recall (Cls II)Novo Nordisk AS

    Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-08 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoFARMAKEIO OUTSOURCING LLC recall (Cls II)Sun Pharmaceutical Industries Ltd

    Testosterone / Triamcinolone Acetonide 25MG/5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0379-01 — Reason: CGMP Deviations: Potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4068-01, b) 1000 Capsules, NDC 0093-4068-10 — Reason: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoProRx LLC recall (Cls II)Novo Nordisk AS

    Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-06 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls II)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-051-88. — Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4067-01, b) 1000 Capsules, NDC 0093-4067-10 — Reason: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoFARMAKEIO OUTSOURCING LLC recall (Cls II)Transdermal Delivery Solutions Corp

    Testosterone 50MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0387-01 — Reason: CGMP Deviations: Potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoHeritage Pharmaceuticals Inc recall (Cls II)Hepion Pharmaceuticals, Inc.

    Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. — Reason: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoFARMAKEIO OUTSOURCING LLC recall (Cls II)Transdermal Delivery Solutions Corp

    Testosterone 62.5 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0383-01 — Reason: CGMP Deviations: Potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoLetco Medical LLC recall (Cls III)QOL Medical LLC

    Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604 — Reason: Labeling: Not Elsewhere Classified — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoEndo USA, Inc. recall (Cls III)Par Pharmaceutical Inc

    Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-127-91 — Reason: Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoProRx LLC recall (Cls II)Novo Nordisk AS

    Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoSamsung Bioepis Co., Ltd. recall (Cls II)Samsung Bioepis Co Ltd

    HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for: Organon LLC, a subsidiary of ORGANON & Co, Jersey City, NJ 07302, Manufactured by: SAMSUN BIOEPIS Co., Ltd, Incheon, Republic of Korea, NDC 78206-183-01. — Reason: Lack of Assurance of Sterility. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoProRx LLC recall (Cls II)Eli Lilly and Co

    Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoFARMAKEIO OUTSOURCING LLC recall (Cls II)Sun Pharmaceutical Industries Ltd

    Testosterone / Triamcinolone Acetonide Pellet (100MG/20MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0367-01 — Reason: CGMP Deviations: Potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoHeritage Pharmaceuticals Inc recall (Cls II)Hepion Pharmaceuticals, Inc.

    Desipramine Hydrochloride Tablets, USP, 150 mg, 50 count bottle (NDC 23155-583-25), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. — Reason: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoKenvue Brands LLC recall (Cls II)JOHNSON & JOHNSON

    TYLENOL, Acetaminophen, Extra Strength, 24 Caplets, 500mg each, distributed by: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division, Fort Washington, PA 19034, NDC: 50580-378-04. — Reason: Defective Container — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls II)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-050-88. — Reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoAmerisource Health Services LLC recall (Cls II)Appco Pharma LLC

    Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 60687-572-32, Individual unit dose: NDC 60687-572-33 — Reason: Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoProRx LLC recall (Cls II)Novo Nordisk AS

    Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoFARMAKEIO OUTSOURCING LLC recall (Cls II)Sun Pharmaceutical Industries Ltd

    Testosterone / Triamcinolone Acetonide, 12.5MG/2.5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0363-01 — Reason: CGMP Deviations: Potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoEndo USA, Inc. recall (Cls III)Par Pharmaceutical Inc

    Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91 — Reason: Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoFARMAKEIO OUTSOURCING LLC recall (Cls II)Sun Pharmaceutical Industries Ltd

    Testosterone / Triamcinolone Acetonide Pellet (37.5MG/7.5MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0380-01 — Reason: CGMP Deviations: Potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoProRx LLC recall (Cls II)Novo Nordisk AS

    Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Nov 5, 2025recall286d agoOtsuka ICU Medical LLC recall (Cls II)Revalesio Corp

    0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC 0990-7984-37 — Reason: Lack of Assurance of Sterility: Potential for flexible container leaks. — Status: Ongoing

    full page →fda recalls ↗
    $TERN52.95-0.03%
    $TEVA36.46-0.84%
    $HEPA
    $TERN52.95-0.03%
    $HEPA
    $TEVA36.46-0.84%
    $JNJ262.42+0.80%